Combined Trabeculectomy with Mitomycinc, Pars Plana Vitrectomy with Panretinal Photocoagulation, and Intravitreal and Intracameral Bevacizumab for Neovascular Glaucoma

Authors

  • Hong-Zin Lin Department of Ophthalmology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Institute of Medical Science, Tzu Chi University, Hualien, Taiwan
  • Yuan-Chieh Lee Department of Ophthalmology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Department of Ophthalmology and Visual Science, Tzu Chi University, Hualien, Taiwan; Institute of Medical Science, Tzu Chi University, Hualien, Taiwan; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan

DOI:

https://doi.org/10.17140/OOJ-1-101

Keywords:

Neovascular glaucoma; Trabeculectomy; Mitomycin C; Pars plana vitrectomy; Endolaser photocoagulation; Intravitreal bevacizumab; Intracameral bevacizumab.

Abstract

Purpose: To report the effectiveness of combined surgery for neovascular glaucoma.
Methods: Six eyes of six consecutive patients with neovascular glaucoma underwent the combined surgery: trabeculectomy with Mitomycin C, Pars Plana Vitrectomy (PPV), endolaserpanretinal photocoagulation, intravitreal and intracameral injection of bevacizumab.
Results: The intraocular pressure returned to normal range soon after operation. The neovascularization of iris regressed in a few days. Mild hyphema developed in three patients. All six
patients had improved or stable visual acuity, and achieved normal intraocular pressure without
antiglaucoma medications three months after operation.
Conclusions: This combined surgery may break the vicious cycle of neovascularglaucoma and
preserve useful vision in these patients.

References

Mietz H, Raschka B, Krieglstein GK. Risk factors for fail-ures of trabeculectomies performed without antimetabolites. Br J Ophthalmol. 1999; 83: 814-821. doi: 10.1136/bjo.83.7.814

Kiuchi Y, Sugimoto R, Nakae K, Saito Y, Ito S. Trabeculec-tomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica. 2006; 220: 383-388. doi: 10.1159/000095865

Kiuchi Y, Nakae K, Saito Y, Ito S, Ito N. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006; 244: 1627-1632. doi: 10.1007/ s00417-006-0321-7

Kolomeyer AM, Seery CW, Emami-Naeimi P, Zarbin MA, Fechtner RD, Bhagat N. Combined pars plana vitrectomy and pars plana Baerveldt tube placement in eyes with neo-vascular glaucoma. Retina. 2015; 35(1): 17-28. doi: 10.1097/ IAE.0000000000000235

Lee SS, Ghosn C, Yu Z, et al. Vitreous VEGF clearance is increased after vitrectomy. Invest Ophthalmol Vis Sci. 2010; 51: 2135-2138. doi: 10.1167/iovs.09-3582

Kotecha A, Spratt A, Ogunbowale L, et al. Intravitreal bevaci-zumab in refractory neovascular glaucoma: a prospective, obser-vational case series. Arch Ophthalmol. 2011; 129: 145-150. doi: 10.1001/archophthalmol.2010.350

Hwang HB, Han JW, Yim HB, Lee NY. Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of ahmed glaucoma valve implantation in patients with neovascu-lar glaucoma: systematic literature review. J Ocul Pharmacol Ther. 2015; 31(4): 198-203. doi: 10.1089/jop.2014.0108

Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ. Outcomes of treatment of neovascular glaucoma with intra-vitreal bevacizumab. Br J Ophthalmol. 2009; 93: 589-593. doi: 10.1136/bjo.2008.151472

Takihara Y, Inatani M, Kawaji T, et al. Combined intravit-real bevacizumab and trabeculectomy with mitomycin C ver-sus trabeculectomy with mitomycin C alone for neovascu-lar glaucoma. J glaucoma. 2011; 20: 196-201. doi: 10.1097/ IJG.0b013e3181d9ce12

Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. In-creased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998; 105(2): 232-237. doi: 10.1016/S0161-6420(98)92782-8

Grewal DS, Jain R, Kumar H, Grewal SP. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology. 2008; 115: 2141-2145.e2. doi: 10.1016/j.ophtha.2008.06.009

Li Z, Van Bergen T, Van de Veire S, et al. Inhibition of vascu-lar endothelial growth factor reduces scar formation after glau-coma filtration surgery. Invest Ophthalmol Vis Sci. 2009; 50: 5217-5225. doi: 10.1167/iovs.08-2662

Downloads

Published

2015-11-13

How to Cite

Hong-Zin Lin, & Yuan-Chieh Lee. (2015). Combined Trabeculectomy with Mitomycinc, Pars Plana Vitrectomy with Panretinal Photocoagulation, and Intravitreal and Intracameral Bevacizumab for Neovascular Glaucoma. The Ophthalmology, 1–4. https://doi.org/10.17140/OOJ-1-101

Issue

Volume 1 Issue 1 2015

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in The Ophthalmology (TOOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.